Leading the industry in peptide & GLP-1 bioanalysis

Proven methods. Faster paths to quality data.

Beyond GLP-1s

High Quality Peptide Bioanalysis with LC–MS/MS

While GLP-1 receptor agonists lead today’s headlines, peptide therapeutics continue expanding across endocrine, oncology and imaging indications. Veloxity Labs keeps early-phase programs on schedule with peptide-savvy LC–MS/MS and phase-aligned documentation.

Our experienced team has supported hundreds of peptide programs—delivering the selectivity, sensitivity and speed sponsors need to advance confidently.

Demonstrated performance

LC–MS/MS bioanalysis of Semaglutide & Tirzepatide

Veloxity’s LC-MS/MS methods quantify semaglutide and tirzepatide in rat plasma and brain tissue with low-ng/mL sensitivity—demonstrating selective, reliable performance across matrices and study types.

Modern systems driving faster results

Integrated Platforms Advancing Peptide Programs

Veloxity pairs scientific expertise with cutting-edge tools to keep study timelines on track:

SCIEX ZenoTOF™ 8600 HRAM system: expanded mass range for intact peptides and proteins; faster method cycles and better interference resolution.
Thermo Scientific™ Watson LIMS™ (Cloud): centralized traceability and automation for GLP/GCP-aligned workflows.
VELO™ Workflow System: fewer manual steps, clearer handoffs, predictable turnaround.

Let’s talk peptides

Plan Your 2026 studies with Veloxity

Veloxity’s peptide platform converts experience into practical speed—reducing setup time, simplifying tech transfer and helping programs reach the clinic faster. Whether you need established GLP-1 assays or custom peptide development, our team delivers the data quality and responsiveness that move studies forward.

Our scientists and business development team are ready to discuss your peptide bioanalysis needs.